Brief: Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing
11/09/2026 21:33
BRIEF-Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing Sept 11 (Reuters) - Skye Bioscience, Inc. SKYE.O:
SKYE BIOSCIENCE - JOHN P. SHARP RESIGNS AS CFO AND PRINCIPAL FINANCIAL OFFICER EFFECTIVE SEPT 8, 2026 - SEC FILING
SKYE BIOSCIENCE - APPOINTS PUNIT DHILLON AS PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER EFFECTIVE SEPT 8, 2026 - SEC FILING
Source text: [ID:n0001628280-26-061558]
Further company coverage: SKYE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsRCS - Redx Pharma Limited - Redx to Present Poster on RXC008 at UEG Week
RCS - Redx Pharma Limited - Redx Announces ROCKETEER Phase 2 Trial for RXC008
Brief: Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing
Brief: Skye Bioscience - Enters $22 Million Securities Purchase Agreement With Redmile Biopharma Investments Iii - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM